AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
Why AbbVie Stock Cruised to an Almost 6% Gain Today
A new expansion project and a win for a peer pharmaceutical company were attracting investors to the shares.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
If you are looking for dividend stocks that can provide a reliable, long-term income stream, consider buying AbbVie, Coca-Cola, and Chevron.
5 Dividend Powerhouses to Buy and Never Sell
These blue-chip giants have paid shareholders through wars, recessions, and pandemics.
8 Best Index Funds to Buy in September 2025
Here are the eight best index funds to add to your portfolio for steady, low-cost growth.
3 Top Dividend Stocks to Buy and Hold Forever
These blue chip dividend stocks offer both income and growth potential.
Where Will AbbVie Be in 5 Years?
This big pharmaceutical company should be significantly bigger five years from now.
1 Top Dividend Stock to Buy and Hold Forever
The stock has outperformed the broader market since its 2013 IPO, and can still do so over the long run.
What Is One of the Best Pharmaceutical Stocks to Buy Right Now?
There aren't many companies in the industry that offer an excellent combination of growth and income.
Valuation
Earnings Transcripts
AbbVie (ABBV) Q2 2025 Earnings Call Transcript
None
AbbVie (ABBV) Q4 2024 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2024.
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2024.
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.